Andrew O'Connor is a technical leader and investor currently involved as a Board Observer for multiple companies, including kea and Robigo. Having previously worked as a VC Summer Associate at In-Q-Tel, O'Connor gained valuable experience connecting technology with strategic investments. They served as COO for Alveolus Bio and ResBiotic, both focusing on innovative health solutions. O'Connor is currently pursuing dual master's degrees at Harvard Business School and the Harvard John A. Paulson School of Engineering and Applied Sciences, building on a strong foundation in chemical engineering from Auburn University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices